Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
November 13, 2024 7:16 AM ESTCantor Fitzgerald analyst Ross Osborn raised the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $3.80 (from $3.50) while maintaining a Overweight rating.
The analyst comments "We reiterate our Overweight and increase our 12-month price target to $3.80 from $3.50 on Organogenesis' ("ORGO") shares following the... More
Organogenesis Holding (ORGO) Tops Q3 EPS by 11c
November 12, 2024 4:33 PM ESTOrganogenesis Holding (NASDAQ: ORGO) reported Q3 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $115.2 million versus the consensus estimate of $108.83 million.
GUIDANCE:
Organogenesis Holding sees FY2024 revenue of $455-480 million, versus the consensus of $456... More
